{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:59:45Z","timestamp":1784717985518,"version":"3.55.0"},"reference-count":23,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["High Altitude Medicine &amp; Biology"],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:p>\n                    Liu, Chunlei, Xu Chen, Ge Guo, Xiang Xu, Xin Li, Qingxia Wei, Yanying Shen, Hanlu Li, Jianxiu Hao, Ya Ping Tian, and Kunlun He. Effects of intermittent normoxia on chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.\n                    <jats:italic toggle=\"yes\">High Alt Med Biol<\/jats:italic>\n                    . 22: 184\u2013192, 2021.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Individuals with chronically low arterial oxygen tension owing to high altitude develop elevated rates of pulmonary hypertension (PH) and right ventricular (RV) hypertrophy. However, the effects of the frequency and duration of normoxic exposure on PH and RV hypertrophy have not been adequately assessed; thus, we aimed to analyze the same.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>PH and RV hypertrophy were induced in 60 rats using a hypobaric chamber. Of these 60 rats, every 10 were exposed to normoxic conditions for 30 minutes once (1T\/D), three times (3T\/D), or five times daily (5T\/D), or for one 150-minute recovery daily (1LT\/D). Furthermore, 10 rats were housed in a normoxic environment, and another 10 were subjected to continuous hypoxia. After 4 weeks, hemodynamic measurements were recorded, and the hearts were harvested for pathomorphological observations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Average pulmonary arterial pressures (PAP) of control rats and those exposed to hypobaric hypoxia were 14.1 and 32.3\u2009mmHg, respectively. After 30 minutes of exposure to normoxia 3T\/D, 5T\/D, or 1LT\/D, PAP values were reduced to 27.1, 27.9, or 26.8\u2009mmHg, respectively. Four weeks of hypoxic exposure elevated the RV\/heart weight (HW) ratios, while exposure to normoxia 3T\/D, 5T\/D, and 1LT\/D significantly reduced RV\/HW. In addition, exposure to normoxia 3T\/D, 5T\/D, 1LT\/D reduced the percentage wall thickness of the pulmonary artery as well as the hypertrophy indices of atrial natriuretic peptide, brain natriuretic peptide, and myosin heavy chain 7 (MYH-7).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Thirty-minute exposure to normoxic conditions of 3T\/D, 5T\/D, or 1LT\/D effectively ameliorates PH and RV thickening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/ham.2020.0110","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T15:27:58Z","timestamp":1621006078000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of Intermittent Normoxia on Chronic Hypoxic Pulmonary Hypertension and Right Ventricular Hypertrophy in Rats"],"prefix":"10.1177","volume":"22","author":[{"given":"Chunlei","family":"Liu","sequence":"first","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."},{"name":"Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Guo","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."},{"name":"Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Wei","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Shen","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Li","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiu","family":"Hao","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Ping","family":"Tian","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."},{"name":"Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlun","family":"He","sequence":"additional","affiliation":[{"name":"Transformation Medicine Centre, Chinese PLA General Hospital, Beijing, China."},{"name":"Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"e_1_3_3_2_1","first-page":"0120157","article-title":"Increased eicosanoid levels in the sugen\/chronic hypoxia model of severe pulmonary hypertension","volume":"10","author":"Al-Husseini A","year":"2004","unstructured":"Al-Husseini A, , Wijesinghe DS, , Farkas L, , Kraskauskas D, , Drake JI, , Van Tassel B, , Abbate A, , Chalfant CE, , and Voelkel NF. (2004). Increased eicosanoid levels in the sugen\/chronic hypoxia model of severe pulmonary hypertension. PLoS One, 10:e0120157.","journal-title":"PLoS One"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.0701985104","article-title":"Two routes to functional adaptation: Tibetan and Andean high-altitude natives","volume":"104","author":"Beall CM","year":"2007","unstructured":"Beall CM. (2007). Two routes to functional adaptation: Tibetan and Andean high-altitude natives. PNAS, 104:8655\u20138660.","journal-title":"PNAS"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-015-9479-6"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2018.0013"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00322.2016"},{"key":"e_1_3_3_7_1","first-page":"36","article-title":"Oxygen therapy for the prevention of hypoxia injury after migration to 3700m plateau On-site study of the role of prevention","volume":"25","author":"Cui JH","year":"2015","unstructured":"Cui JH, , Cui YY, , and Zhang JC. (2015). Oxygen therapy for the prevention of hypoxia injury after migration to 3700m plateau On-site study of the role of prevention. Highl Med Res J, 25:36.","journal-title":"Highl Med Res J"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2017.01.002"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10237-008-0133-2"},{"key":"e_1_3_3_10_1","first-page":"8381653","article-title":"Thin air resulting in high pressure: Mountain sickness and hypoxia-induced pulmonary hypertension","volume":"2017","author":"Grimminger J","year":"2017","unstructured":"Grimminger J, , Richter M, , Tello K, , Sommer N, , Gall H, , and Ghofran HA. (2017). Thin air resulting in high pressure: Mountain sickness and hypoxia-induced pulmonary hypertension. Can Respir J, 2017:8381653.","journal-title":"Can Respir J"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2016.03.004"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1152\/ajplung.00480.2005","article-title":"Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat","volume":"291","author":"Kantores C","year":"2006","unstructured":"Kantores C, , McNamara PJ, , Teixeira L, , Engelberts D, , Murthy P, , Kavanagh BP, , and Jankov RP. (2006). Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat. Am J Physiol Lung Cell Mol Physiol, 291:L912\u2013L922.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"e_1_3_3_13_1","first-page":"993","article-title":"Effect of intermittent normoxia on chronic hypoxic pulmonary hypertension, right ventricular hypertrophy, and polycythemia in rats","volume":"121","author":"Kay JM","year":"1980","unstructured":"Kay JM. (1980). Effect of intermittent normoxia on chronic hypoxic pulmonary hypertension, right ventricular hypertrophy, and polycythemia in rats. Am Rev Respir Dis, 121:993\u20131001.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.RES.0000138952.16382.ad","article-title":"Chronic hypoxia\u2013induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells","volume":"95","author":"Lin MJ","year":"2004","unstructured":"Lin MJ, , Leung GPH, , Zhang WM, , Yang XR, , Yip KP, , Tse CM, , and Sham JSK. (2004). Chronic hypoxia\u2013induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells. Circ Res, 95:496\u2013505.","journal-title":"Circ Res"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.14814\/phy2.13157","article-title":"Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension","volume":"5","author":"Liu AP","year":"2017","unstructured":"Liu AP, , Philip J, , Vinnakota KC, , Van den Bergh F, , Tabima DM, , Hacker T, , Beard DA, , and Chesler NC. (2017). Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension. Physiol Rep, 5:e13157.","journal-title":"Physiol Rep"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.resp.2014.06.001","article-title":"Fasudil reversed MCT-induced and chronic hypoxia-induced pulmonary hypertension by attenuating oxidative stress and inhibiting the expression of Trx1 and HIF-1alpha","volume":"201","author":"Liu M","year":"2014","unstructured":"Liu M, , Wang Y, , Zheng L, , Zheng W, , Dong K, , Chen S, , Zhang B, , and Li Z. (2014). Fasudil reversed MCT-induced and chronic hypoxia-induced pulmonary hypertension by attenuating oxidative stress and inhibiting the expression of Trx1 and HIF-1alpha. Respir Physiol Neurobiol, 201:38\u201346.","journal-title":"Respir Physiol Neurobiol"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00114.2018"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200407-037MS"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1165\/rcmb.2008-0132OC","article-title":"Rosiglitazone attenuates chronic hypoxia\u2013induced pulmonary hypertension in a mouse model","volume":"42","author":"Nisbet RE","year":"2010","unstructured":"Nisbet RE, , Bland JM, , Kleinhenz DJ, , Mitchell PO, , Walp ER, , Sutliff RL, , and Hart CM. (2010). Rosiglitazone attenuates chronic hypoxia\u2013induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol, 42:482\u2013490.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02988.x"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/01.CIR.102.23.2892","article-title":"Chronic hypoxia stimulates periarterial sympathetic nerve development in chicken embryo","volume":"102","author":"Ruijtenbeek K","year":"2000","unstructured":"Ruijtenbeek K, , le Noble FA, , Janssen GM, , Kessels CG, , Fazzi GE, , Blanco CE, , and De Mey JG. (2000). Chronic hypoxia stimulates periarterial sympathetic nerve development in chicken embryo. Circulation, 102:2892\u20132897.","journal-title":"Circulation"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2018.11.005"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf A","year":"2013","unstructured":"Vonk-Noordegraaf A, , Haddad F, , Chin KM, , Forfia PR, , Kawut SM, , Lumens J, , Naejie R, , Newman J, , Oudiz RJ, , Provencher S, , Torbicki A, , Voelkel NF, , and Hassoun PM. (2013). Right heart adaptation to pulmonary arterial hypertension physiology and pathobiology. J Am Coll Cardiol, 62:D22\u2013D23.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040502"}],"container-title":["High Altitude Medicine &amp; Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/ham.2020.0110","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ham.2020.0110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ham.2020.0110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:24:55Z","timestamp":1777447495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/ham.2020.0110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6,1]]}},"alternative-id":["10.1089\/ham.2020.0110"],"URL":"https:\/\/doi.org\/10.1089\/ham.2020.0110","relation":{},"ISSN":["1527-0297","1557-8682"],"issn-type":[{"value":"1527-0297","type":"print"},{"value":"1557-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}